-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.
-
Summary
-
Oncotelic Therapeutics, Inc. quarterly and annual Interest Paid, Excluding Capitalized Interest, Operating Activities history and change rate from 2020 to Q1 2025.
- Oncotelic Therapeutics, Inc. Interest Paid, Excluding Capitalized Interest, Operating Activities for the quarter ending 31 Mar 2025 was $94,773, unchanged year-over-year.
- Oncotelic Therapeutics, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2024 was $365,940, a 6.3% decline from 2023.
- Oncotelic Therapeutics, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2023 was $390,561, a 1.87% decline from 2022.
- Oncotelic Therapeutics, Inc. annual Interest Paid, Excluding Capitalized Interest, Operating Activities for 2022 was $397,995, a 32.9% increase from 2021.
Interest Paid, Excluding Capitalized Interest, Operating Activities, Quarterly (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Quarterly Change (%)
Interest Paid, Excluding Capitalized Interest, Operating Activities, Annual (USD)
Interest Paid, Excluding Capitalized Interest, Operating Activities, YoY Annual Change (%)